Atlantic Healthcare Names US Management
Atlantic Healthcare plc. has named the management team which will lead its newly established US commercial and business development operations, based in North Carolina. The specialty pharma company, which focuses on gastrointestinal disorders, has appointed Sireesh Appajosyula vice president (VP) product commercialisation, Jonathan Drutz VP corporate and business development and Jordan Zwick director of corporate and business development. Appajosyula joins Atlantic from Salix Pharmaceuticals, where he led the company’s inflammatory bowel disease division. Drutz has been involved in a variety of life science ventures, acting as a business development executive, investor and consultant. Zwick most recently led business development and corporate strategy at Chimerix, having previously been at Salix and Medtronic.
You may also be interested in...
Executives On The Move: PYC Therapeutics Gets Chief Development Officer, New Chief Commercial Officer At Everest Medicines
New Directors Join Ambrx, Synedgen and Cogent Biosciences.
Coronavirus Update: Moderna’s Variant-Targeting Vaccine Moves Into Trial, J&J Looks Set For US Authorization
A round up of COVID-19 developments, also including news on the EMA beginning a rolling review of Celltrion's antibody therapy, and progress for Novavax and Moderna in Japan.
A round-up of the latest developments, including Celltrion’s new antibody cocktail and SK Biosience and Novavax expanding their collaboration.